NCT04602689View on ClinicalTrials.gov

Fibrin Glue After ESD for High Risk Patients of Bleeding

NACompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

October 30, 2020

Primary Completion Date

July 14, 2022

Study Completion Date

July 14, 2022

Conditions
Early Gastric CancerGastric Adenoma
Interventions
DRUG

Human fibrinogen concentrate

Spread the Human fibrinogen concentrate/Aprotinin/Thrombin/Calcium chloride hydrate mixture on iatrogenic ulcer after ESD

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

Asan Medical Center
All Listed Sponsors
collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Asan Medical Center

OTHER

lead

Seoul National University Hospital

OTHER

NCT04602689 - Fibrin Glue After ESD for High Risk Patients of Bleeding | Biotech Hunter | Biotech Hunter